{"id":"W4385155802","doi":"10.1007/s13555-023-00948-6","title":"Abrocitinib 100 mg Once Daily for Moderate-to-Severe Atopic Dermatitis: A Review of Efficacy and Safety, and Expert Opinion on Use in Clinical Practice","year":2023,"lang":"en","type":"review","venue":"Dermatology and Therapy","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"ca_institutions":"SKiN Health; Queen's University","funders":"Pfizer","keywords":"JADE (particle detector); Medicine; Tolerability; Atopic dermatitis; Clinical Practice; Expert opinion; Regimen; Dermatology; Adverse effect; Intensive care medicine; Internal medicine; Family medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004376155,0.0004072088,0.002828601,0.0002206943,0.0001056494,0.00001956274,0.0001126854,0.0005967413,0.00001128541],"category_scores_gemma":[0.001513693,0.0003227958,0.0001959305,0.0002063428,0.0002569483,0.0001464709,0.00007192647,0.0004502984,0.00001052449],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001411205,"about_ca_system_score_gemma":0.0002159383,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000009735571,"about_ca_topic_score_gemma":0.00000374483,"domain_scores_codex":[0.9968161,0.0007798249,0.001375648,0.000594384,0.0001306732,0.000303349],"domain_scores_gemma":[0.9936906,0.005193941,0.0004416816,0.0003685886,0.0001028785,0.0002022955],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001767766,0.0004867684,0.001105621,0.07461365,0.0008042608,0.0004811327,0.0002906644,1.369682e-7,8.431387e-8,0.001491081,0.0168614,0.9020974],"study_design_scores_gemma":[0.004123801,0.0001898222,0.00236324,0.07251124,0.0002059339,0.003979234,0.00002814708,0.00001183269,7.186585e-7,0.0001305187,0.9161807,0.0002748121],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0005587704,0.9931762,0.00004174011,0.003135554,0.0001984788,0.00263606,0.00007004421,0.00004291941,0.0001401979],"genre_scores_gemma":[0.0002271684,0.986026,0.0003964697,0.01272942,0.00006077604,0.0002836748,0.0001937364,0.00004823084,0.00003446622],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9018226,"threshold_uncertainty_score":0.9999224,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.123936206391958,"score_gpt":0.4554051293645459,"score_spread":0.3314689229725879,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}